TG Therapeutics, Inc. (TGTX) Stock price, Description, News & Info

#Thinksabio latest news

TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced EnrollmentPhase 3 trial to evaluate two subcutaneous BRIUMVI dosing regimens